Pancreatic Cancer Research

ResearcherQueen Mary University of LondonActive in the last 2 years

Sara Maria David Trabulo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3178-2119; OpenAlex author ID A5052457337. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
64
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 15

  1. PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-3475↗
  2. A Self-Assembled 3D Model Demonstrates How Stiffness Educates Tumor Cell Phenotypes and Therapy Resistance in Pancreatic Cancer. Co-author DOI 10.1002/adhm.202301941↗
  3. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2021-325564↗
  4. Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology. First author DOI 10.1038/s41467-021-25921-9↗
  5. PPAR-delta acts as a metabolic master checkpoint for metastasis in pancreatic cancer Co-author DOI 10.1101/2021.11.15.468579↗
  6. Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus. Co-author DOI 10.7150/thno.38702↗
  7. Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Co-author DOI 10.1038/s41467-019-11752-2↗
  8. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Co-author DOI 10.1038/s41467-018-03962-x↗
  9. Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells. Co-author DOI 10.1016/j.bbagen.2017.01.035↗
  10. ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. Co-author DOI 10.1038/onc.2016.459↗
  11. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. First author DOI 10.1136/gutjnl-2014-308470↗
  12. Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms. First author DOI 10.1158/1078-0432.ccr-14-1399↗
  13. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. Co-author DOI 10.1158/1535-7163.mct-13-0948↗
  14. Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts. First author DOI 10.1371/journal.pone.0066371↗
  15. Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. Co-author DOI 10.1371/journal.pone.0076518↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher Heeschen · 14 shared papers, 2013–2025 · strength 1.19
  2. Bruno Sáinz · 7 shared papers, 2013–2025 · strength 0.56
  3. Patricia Sancho Andrés · 4 shared papers, 2013–2025 · strength 0.43
  4. Mert Erkan · 4 shared papers, 2014–2023 · strength 0.33
  5. Daniela Loessner · 2 shared papers, 2021–2024 · strength 0.30
  6. David Osuna de la Peña · 2 shared papers, 2021–2024 · strength 0.30
  7. Ying Liu · 2 shared papers, 2021–2024 · strength 0.30
  8. Rita Teresa Lawlor · 2 shared papers, 2021–2024 · strength 0.30
  9. Aldo Scarpa Scarpa · 2 shared papers, 2021–2024 · strength 0.30
  10. Petra Jagušt · 2 shared papers, 2021–2025 · strength 0.27
  11. Sarah Courtois · 2 shared papers, 2021–2025 · strength 0.27
  12. Quan Zheng · 2 shared papers, 2021–2025 · strength 0.27
  13. Beatriz Parejo-Alonso · 2 shared papers, 2021–2025 · strength 0.27
  14. Pilar Espiau-Romera · 2 shared papers, 2021–2025 · strength 0.27
  15. Manuel M. Hidalgo · 5 shared papers, 2013–2015 · strength 0.20
  16. Oliver M.T. Pearce · 1 shared paper, 2024 · strength 0.18
  17. Matthias M. Gaida · 1 shared paper, 2025 · strength 0.18
  18. Andrés Gordo-Ortiz · 1 shared paper, 2025 · strength 0.18
  19. Michele Cioffi · 4 shared papers, 2013–2015 · strength 0.17
  20. Patrick Christian Hermann · 2 shared papers, 2013–2023 · strength 0.15
  21. Sladjana Zagorac · 2 shared papers, 2018–2019 · strength 0.14
  22. Justin Stebbing · 2 shared papers, 2018–2019 · strength 0.14
  23. Leandro Castellano · 2 shared papers, 2018–2019 · strength 0.14
  24. Niccola Funel · 2 shared papers, 2018–2019 · strength 0.14
  25. Silvia Ottaviani · 2 shared papers, 2018–2019 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.